Tranexamic acid (promotes blood clotting) or placebo and direct pressure for treatment of nosebleeds in Emergency Department

Enter your info and the study team will contact you soon!
Your data is securely stored and only shared with the research team
Data is not saved in preview.
"Can tranexamic acid reduce the duration of a nosebleed?"
Age:
18 to 100 years old
Gender:
Any
Healthy Volunteers:
No
Keywords:
nosebleed
Type:
Drug study
Investigator:
Description
This study will be evaluating the benefits of topical intranasal tranexamic acid (promotes blood clotting) for patients with epistaxis (nosebleeds). Tranexamic acid is not currently approved by the FDA for the treatment of nosebleeds
This study requires
Treatment for nosebleed in ER
Treatment with Tranexamic acid and direct pressure or placebo and direct pressure
Follow up phone call
Who can participate?
Inclusion Criteria:

- Diagnosed with anterior epistaxis


Exclusion Criteria:

- Unable to consent, do not have a valid telephone number, pregnant women, prisoners, cognitively impaired individuals, diagnosis of posterior epistaxis, major trauma, bleeding disorder (such as thrombocytopenia or hemophilia), hemodynamically unstable, or had a known hypersensitivity to study medication
Resources
Schedule
Study duration and period
Treatment period: 30 minutes Follow up call: within one week
Recruitment period
From Feb. 4, 2016
Location
Department of Emergency Medicine
4150 V Street
Suite 2100
Sacramento, CA 95817
Research Topic
Conditions:
  • Epistaxis

Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.


Sending

Send SMS with Study Info:

SMS Sent!

Share Study Info via Email:


E-mail Preview